It took more than 50 years for Marthe Gautier to set the record straight about her discovery of the genetic cause of Down ...

Last week, the BBC broadcast interviews with two couples who had agreed to abortions after a hospital told them it had ...

After winning a breakthrough therapy designation for its Hunter syndrome enzyme replacement therapy, Denali Therapeutics is ...

Two women had abortions after an NHS trust mistakenly told them their babies had serious conditions, the BBC has learned.

With the rise of countercultural movements in the ’60s and ’70s, pot became a symbol of rebellion, peace and freedom. Many of today’s parents fondly remember those days. But that was then, and ...

About 1,500 babies are born each year at the Brantford General Hospital (BGH), and 250 are admitted to the hospital’s ...

More than 1,000 genes may serve as possible treatment targets for individuals with kidney disease, according to a new study, ...

The FDA approved an apomorphine hydrochloride infusion device (Onapgo) to treat motor fluctuations in adults with advanced ...

Three people with a muscle-destroying disease destined to worsen got a little stronger when an implanted device zapped their ...

Denali Therapeutics DNLI reported primary analysis data from an early to mid-stage study of its pipeline candidate, tividenofusp alfa (DNL310), in 47 patients with Hunter syndrome (MPS II) over a ...

After combing through 4,000 existing medications, an artificial intelligence tool helped uncover one that saved the life of a patient with idiopathic multicentric Castleman's disease (iMCD).

H.I.V. treatment and services were funded through ... The pause on aid and the stripping down of U.S.A.I.D. have delivered a “system shock,” said Christine Stegling, a deputy executive ...